skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 5,087  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes. Reply
Material Type:
Article
Add to My Research

Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes. Reply

The New England journal of medicine, 2023-12, Vol.389 (24), p.2302-2303 [Peer Reviewed Journal]

EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2312837 ;PMID: 38091540

Full text available

2
1 H -Pyrazolo[3,4- b ]pyridines: Synthesis and Biomedical Applications
Material Type:
Article
Add to My Research

1 H -Pyrazolo[3,4- b ]pyridines: Synthesis and Biomedical Applications

Molecules (Basel, Switzerland), 2022-03, Vol.27 (7) [Peer Reviewed Journal]

EISSN: 1420-3049 ;PMID: 35408636

Full text available

3
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia
Material Type:
Article
Add to My Research

Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia

Blood, 2020-02, Vol.135 (7), p.463-471 [Peer Reviewed Journal]

2020 American Society of Hematology ;2020 by The American Society of Hematology. ;2020 by The American Society of Hematology 2020 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2019002140 ;PMID: 31841594

Full text available

4
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Material Type:
Article
Add to My Research

Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

The New England journal of medicine, 2018-07, Vol.379 (1), p.54-63 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1717002 ;PMID: 29972759

Full text available

5
Sotorasib for Lung Cancers with KRAS p.G12C Mutation
Material Type:
Article
Add to My Research

Sotorasib for Lung Cancers with KRAS p.G12C Mutation

The New England journal of medicine, 2021-06, Vol.384 (25), p.2371-2381 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2103695 ;PMID: 34096690

Full text available

6
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
Material Type:
Article
Add to My Research

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

The Lancet infectious diseases, 2016-07, Vol.16 (7), p.828-837 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 01, 2016 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(16)00071-2 ;PMID: 26969258 ;CODEN: LANCAO

Full text available

7
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Material Type:
Article
Add to My Research

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

The New England journal of medicine, 2018-02, Vol.378 (7), p.615-624 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1711948 ;PMID: 29231094

Full text available

8
Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer
Material Type:
Article
Add to My Research

Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer

Cancer research (Chicago, Ill.), 2016-04, Vol.76 (8), p.2301-2313 [Peer Reviewed Journal]

2016 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.can-15-0728 ;PMID: 27020857

Full text available

9
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Material Type:
Article
Add to My Research

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet (British edition), 2017-01, Vol.389 (10064), p.56-66 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 7, 2017 ;2017. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)32453-9 ;PMID: 27932229 ;CODEN: LANCAO

Full text available

10
Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study
Material Type:
Article
Add to My Research

Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study

Neurology, 2018-12, Vol.91 (24), p.e2222-e2232 [Peer Reviewed Journal]

2018 American Academy of Neurology ;Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2018 American Academy of Neurology ;ISSN: 0028-3878 ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000006641 ;PMID: 30446595

Full text available

11
Molecular therapies and precision medicine for hepatocellular carcinoma
Material Type:
Article
Add to My Research

Molecular therapies and precision medicine for hepatocellular carcinoma

Nature reviews. Clinical oncology, 2018-10, Vol.15 (10), p.599-616 [Peer Reviewed Journal]

COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Oct 2018 ;Springer Nature Limited 2018. ;ISSN: 1759-4774 ;EISSN: 1759-4782 ;DOI: 10.1038/s41571-018-0073-4 ;PMID: 30061739

Full text available

12
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial
Material Type:
Article
Add to My Research

Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial

Clinical cancer research, 2021-08, Vol.27 (16), p.4491-4499 [Peer Reviewed Journal]

2021 The Authors; Published by the American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-21-0611 ;PMID: 34078652

Full text available

13
Treating cancer with selective CDK4/6 inhibitors
Material Type:
Article
Add to My Research

Treating cancer with selective CDK4/6 inhibitors

Nature reviews. Clinical oncology, 2016-07, Vol.13 (7), p.417-430 [Peer Reviewed Journal]

COPYRIGHT 2016 Nature Publishing Group ;COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group Jul 2016 ;ISSN: 1759-4774 ;EISSN: 1759-4782 ;DOI: 10.1038/nrclinonc.2016.26 ;PMID: 27030077 ;CODEN: AJHYE6

Full text available

14
MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression
Material Type:
Article
Add to My Research

MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression

Journal of clinical oncology, 2016-03, Vol.34 (7), p.721-730 [Peer Reviewed Journal]

2016 by American Society of Clinical Oncology. ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2015.63.4600 ;PMID: 26729443

Full text available

15
Camrelizumab Plus Apatinib in Extensive-Stage SCLC (PASSION): A Multicenter, Two-Stage, Phase 2 Trial
Material Type:
Article
Add to My Research

Camrelizumab Plus Apatinib in Extensive-Stage SCLC (PASSION): A Multicenter, Two-Stage, Phase 2 Trial

Journal of thoracic oncology, 2021-02, Vol.16 (2), p.299-309 [Peer Reviewed Journal]

2020 ;Copyright © 2020. Published by Elsevier Inc. ;ISSN: 1556-0864 ;EISSN: 1556-1380 ;DOI: 10.1016/j.jtho.2020.10.002 ;PMID: 33166719

Full text available

16
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial
Material Type:
Article
Add to My Research

Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial

The lancet oncology, 2020-07, Vol.21 (7), p.923-934 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;Attribution - NonCommercial ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30168-6 ;PMID: 32511981

Full text available

17
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032
Material Type:
Article
Add to My Research

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032

Journal of clinical oncology, 2015-08, Vol.33 (24), p.2646-2654 [Peer Reviewed Journal]

2015 by American Society of Clinical Oncology. ;2015 by American Society of Clinical Oncology 2015 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2014.60.1591 ;PMID: 26169613

Full text available

18
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
Material Type:
Article
Add to My Research

Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

Journal of clinical oncology, 2016-05, Vol.34 (13), p.1448-1454 [Peer Reviewed Journal]

2016 by American Society of Clinical Oncology. ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2015.63.5995 ;PMID: 26884585

Full text available

19
Cabozantinib in patients with advanced RET -rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial
Material Type:
Article
Add to My Research

Cabozantinib in patients with advanced RET -rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial

The lancet oncology, 2016-12, Vol.17 (12), p.1653-1660 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 01, 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(16)30562-9 ;PMID: 27825636 ;CODEN: LANCAO

Full text available

20
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial
Material Type:
Article
Add to My Research

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial

The Lancet (British edition), 2019-10, Vol.394 (10206), p.1335-1343 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31872-0 ;PMID: 31492505

Full text available

Results 1 - 20 of 5,087  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (4,753)

Refine My Results

Creation Date 

From To
  1. Before 1973  (107)
  2. 1973 To 1984  (386)
  3. 1985 To 1996  (275)
  4. 1997 To 2009  (1,245)
  5. After 2009  (3,079)
  6. More options open sub menu

Language 

  1. English  (4,970)
  2. Japanese  (771)
  3. German  (43)
  4. French  (31)
  5. Spanish  (18)
  6. Chinese  (12)
  7. Portuguese  (9)
  8. Swedish  (7)
  9. Polish  (5)
  10. Czech  (5)
  11. Russian  (4)
  12. Italian  (4)
  13. Hungarian  (1)
  14. Norwegian  (1)
  15. Turkish  (1)
  16. More options open sub menu

Searching Remote Databases, Please Wait